Company-Led Recall on DOCETAXEL VIAL 20MG PFZ 2ML & DOCETAXEL VIAL 160MG PFZ 16ML

Recalls and Alerts

Company-led Recall

Company-Led Recall on DOCETAXEL VIAL 20MG PFZ 2ML & DOCETAXEL VIAL 160MG PFZ 16ML

Pfizer UK Limited is recalling the below batches. This is because routine stability testing has identified that levels of a known impurity, 10-oxo-docetaxel, may exceed the acceptable level at end of shelf-life.

Please visit the: MHRA website for more details on this drug alert.

The affected products' details are as follows:

PIP Code	Product Description	Supplier	Affected Batch
8120875	DOCETAXEL VIAL 20MG PFZ 2ML	PFIZER LTD	S0150518
8120867	DOCETAXEL VIAL 160MG PFZ 16ML	PFIZER LTD	S0390218 S0120218

Please do not consolidate any stock for return. All returns must be from the original delivery address. Any product(s) returned from non-Pfizer accounts will be retained by the distribution centre and not returned. Credit for these returned products must be obtained from the supplier from where the product was purchased.

All Stock must be returned to Alliance Healthcare before the 19th September 2019.

For medical information please contact Pfizer Medical Information Department on 01304 616161

Recipients of this Drug Alert should bring it to the attention of relevant contacts.

If you have any questions, then please contact your local Service Centre Customer Services team.